Skip to main content
Log in

Aufmerksamkeitsdefizit-Hyperaktivitäts-Störung

Arterielle Hypertonie bei ADHS im Kindes- und Jugendalter

Attention deficit hyperactivity disorder

Arterial hypertension by ADHD in childhood and adolescence

  • Arzneimitteltherapie
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Europäische Kommission, www.ema.europa.eu/htms/human/referral/article31/methylphenidate.htm

  2. Europäisches Parlament (2001) Richtlinie 2001/83/EG des europäischen Parlaments und des Rates vom 6. November 2001 zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel. Europäische Union, Straßburg, eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2001L0083:20070126:de:PDF

  3. Gould MS, Walsh BT, Munfakh JL et al (2009) Sudden death and use of stimulant medications in youths. Am J Psychiatry 166:992–1001

    Article  PubMed  Google Scholar 

  4. Huss M, Hölling H, Kurth BM, Schlack R (2008) How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgement of health care professionals: results of the German health and examination survey (KiGGS). Eur Child Adolesc Psychiatry [Suppl 1] 17:52–58

  5. Perrin JM, Friedman RA, Knilans TK, the Black Box Working Group and the Section on Cardiology and Cardiac Surgery (2008) Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics 122:451–453

    Article  PubMed  Google Scholar 

  6. Samuels JA, Franco K, Wan F, Sorof JM (2006) Effect of stimulants on 24-h blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol 21:92–95

    Article  PubMed  Google Scholar 

  7. Schwabe U, Paffrath D (2008) Arzneiverordnungs-Report 2007. Springer, Berlin Heidelberg New York

  8. Schwabe U, Paffrath D (2009)Arzneiverordnungs-Report 2009. Springer, Berlin Heidelberg New York

  9. Stowe CD, Gardner SF, Gist CC et al (2002) 24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy. Ann Pharmacother 36:1142–1149

    Article  CAS  PubMed  Google Scholar 

  10. Vetter VL, Elia J, Erickson C et al (2008) Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs. A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young, Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation 117:2407–2423

    Article  PubMed  Google Scholar 

  11. Wernicke JF, Faries D, Girod D et al (2003) Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf 26:729–740

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Paul.

Additional information

M. Hulpke-Wette und T. Paul für die Kommission für Arzneimittelsicherheit im Kindesalter (KASK) der DGKJ

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hulpke-Wette, M., Paul, T. Aufmerksamkeitsdefizit-Hyperaktivitäts-Störung. Monatsschr Kinderheilkd 158, 489–492 (2010). https://doi.org/10.1007/s00112-010-2219-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-010-2219-z

Navigation